Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription 29.04.2024 4 AIDS 3 AIDS Res Hum Retroviruses 1 BMC Immunol 4 Clin Infect Dis 3 HIV Med 1 J Clin Invest 2 J Infect Dis 2 J Med Virol 1 J Virol 2 Lancet 1 Lancet Infect Dis 1 MMWR Morb Mortal Wkly Rep 1 PLoS Comput Biol 3 PLoS One 1 PLoS Pathog 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. GEORGIADIS N, Papamichail D, Lytras T, Halkitis PN, et al
   The impact of HIV pre-exposure prophylaxis on bacterial sexually transmitted infection occurrence in MSM: A Systematic Review and Meta-analysis.
   AIDS. 2024 Jan 12. doi: 10.1097/QAD.0000000000003837.
   PubMed         Abstract available
   
   
2. FILIP I
   Liver health matters: targeting modifiable factors to reduce the risk of advanced liver disease in people with HIV.
   AIDS. 2024 Apr 23. doi: 10.1097/QAD.0000000000003915.
   PubMed        
   
   
3. SAURA-LAZARO A, Augusto O, Fernandez-Luis S, Lopez-Varela E, et al
   HIV care retention in three multi-month ART dispensing: a retrospective cohort study in Mozambique.
   AIDS. 2024 Apr 23. doi: 10.1097/QAD.0000000000003913.
   PubMed         Abstract available
   
   
4. ZHAO J, Dong Y, Clark E, Garcia JM, et al
   Risk and predictors of penile cancer in US Veterans with HIV.
   AIDS. 2024 Apr 23. doi: 10.1097/QAD.0000000000003914.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

5. HAYASHIDA T, Tran LK, Dang AL, Nagai M, et al
   Identification of New Circulating Recombinant Form of HIV-1 CRF127_07109 in Northern Vietnam.
   AIDS Res Hum Retroviruses. 2024 Apr 26. doi: 10.1089/AID.2024.0022.
   PubMed         Abstract available
   
   
6. LI W, Feng Y, Han J, Wang X, et al
   Characterization of two HIV-1 strains with novel unique recombinant genome in Hebei, China.
   AIDS Res Hum Retroviruses. 2024 Apr 26. doi: 10.1089/AID.2024.0006.
   PubMed         Abstract available
   
   
7. OLIVA-SANCHEZ PF, Landeros-Lopez S, Rosas-Dossetti MM, Grobeisen-Levin S, et al
   Comparison of four predictive scores for cardiovascular risk in Mexican people living with HIV.
   AIDS Res Hum Retroviruses. 2024 Apr 26. doi: 10.1089/AID.2023.0085.
   PubMed         Abstract available
   
   

   
   BMC Immunol

8. ASSOGBA YP, Adechina AP, Tchiakpe E, Nouatin OP, et al
   Advanced in immunological monitoring of HIV infection: profile of immune cells and cytokines in people living with HIV-1 in Benin.
   BMC Immunol. 2024;25:22.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

9. HOLT LM, Short WR, Momplaisir F, Hyun E, et al
   Bictegravir Use During Pregnancy: A Multi-Center Retrospective Analysis Evaluating HIV Viral Suppression and Perinatal Outcomes.
   Clin Infect Dis. 2024 Apr 26:ciae218. doi: 10.1093.
   PubMed         Abstract available
   
   
10. TUSCH E, Ryom L, Pelchen-Matthews A, Mocroft A, et al
    Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
    Clin Infect Dis. 2024 Apr 26:ciae228. doi: 10.1093.
    PubMed         Abstract available
    
    
11. ROSENBERG NE, Shook-Sa BE, Young AM, Zou Y, et al
    An HIV-1 risk assessment tool for women aged 15-49 in African countries: A pooled analysis across 15 nationally representative surveys.
    Clin Infect Dis. 2024 Apr 24:ciae211. doi: 10.1093.
    PubMed         Abstract available
    
    
12. MWESIGWA B, Sawe F, Oyieko J, Mwakisisile J, et al
    Safety and Immunogenicity of Accelerated Heterologous Two-dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
    Clin Infect Dis. 2024 Apr 24:ciae215. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

13. BULLO M, Kierszenowicz T, Acosta MC, Rolon MJ, et al
    Telemedicine in HIV health care during the COVID-19 pandemic: An implementation research study in Buenos Aires, Argentina.
    HIV Med. 2024 Apr 24. doi: 10.1111/hiv.13646.
    PubMed         Abstract available
    
    
14. DINESHA TR, Boobalan J, Kumar CV, Manikandan P, et al
    HIV-1 low-level viraemia predicts virological failure in first-line and second-line ART-experienced individuals in India: A retrospective longitudinal study.
    HIV Med. 2024 Apr 25. doi: 10.1111/hiv.13641.
    PubMed         Abstract available
    
    
15. JOHN M, Williams L, Nolan G, Bonnett M, et al
    Real-world use of long-acting cabotegravir and rilpivirine: 12-month results of the inJectable Antiretroviral therapy feasiBility Study (JABS).
    HIV Med. 2024 Apr 21. doi: 10.1111/hiv.13647.
    PubMed         Abstract available
    
    

    
    J Clin Invest

16. WHITEHILL GD, Joy J, Marino FE, Krause RJ, et al
    Autologous neutralizing antibody responses after antiretroviral therapy in acute and early HIV-1.
    J Clin Invest. 2024 Apr 23:e176673. doi: 10.1172/JCI176673.
    PubMed         Abstract available
    
    

    
    J Infect Dis

17. RIDDLER SA, Kelly CW, Hoesley CJ, Ho KS, et al
    A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention.
    J Infect Dis. 2024 Apr 24:jiae211. doi: 10.1093.
    PubMed         Abstract available
    
    
18. GILLIS N, Dickey BL, Colin-Leitzinger C, Tang YH, et al
    Clonal hematopoiesis in patients with HIV and cancer.
    J Infect Dis. 2024 Apr 24:jiae212. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

19. LIRA GS, Ota VA, Melo MQS, Castineiras ACP, et al
    Mpox outbreak in Rio de Janeiro, Brazil: A translational approach.
    J Med Virol. 2024;96:e29621.
    PubMed         Abstract available
    
    
20. LI Y, Zhang X, Huang Y, Gao L, et al
    The prevalence of Human Immunodeficiency Virus infection among voluntary blood donors in mainland China: A systematic review and meta-analysis.
    J Med Virol. 2024;96:e29599.
    PubMed         Abstract available
    
    

    
    J Virol

21. PERSAUD AT, Khela J, Fernandes C, Chaphekar D, et al
    Virion-incorporated CD14 enables HIV-1 to bind LPS and initiate TLR4 signaling in immune cells.
    J Virol. 2024 Apr 25:e0036324. doi: 10.1128/jvi.00363.
    PubMed         Abstract available
    
    

    
    Lancet

22. TUTLAM NT, Kizito S, Liyew TW, Ssewamala FM, et al
    HIV among refugee youth in Uganda: unmasking the crisis.
    Lancet. 2024;403:1536-1537.
    PubMed        
    
    
23. 
    Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

24. JIN SL, Kolis J, Parker J, Proctor DA, et al
    Social histories of public health misinformation and infodemics: case studies of four pandemics.
    Lancet Infect Dis. 2024 Apr 19:S1473-3099(24)00105.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

25. STADELMAN-BEHAR AM, Gehre MN, Atallah L, Clarke T, et al
    Investigation of Presumptive HIV Transmission Associated with Receipt of Platelet-Rich Plasma Microneedling Facials at a Spa Among Former Spa Clients - New Mexico, 2018-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:372-376.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

26. SUN C, Fang R, Salemi M, Prosperi M, et al
    DeepDynaForecast: Phylogenetic-informed graph deep learning for epidemic transmission dynamic prediction.
    PLoS Comput Biol. 2024;20:e1011351.
    PubMed         Abstract available
    
    

    
    PLoS One

27. KIMBALL S, Reynoso M, McKnight C, Des Jarlais D, et al
    Hepatitis C treatment outcomes among people who inject drugs experiencing unstable versus stable housing: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0302471.
    PubMed         Abstract available
    
    
28. ADETOKUNBOH OO, Are EB
    Spatial distribution and determinants of HIV high burden in the Southern African sub-region.
    PLoS One. 2024;19:e0301850.
    PubMed         Abstract available
    
    
29. AYELE AD, Kassa BG, Mihretie GN, Belay HG, et al
    Level of adherence to option B+ program and associated factors among HIV-positive women in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0298119.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

30. KUZMINA A, Sadhu L, Hasanuzzaman M, Fujinaga K, et al
    Direct and indirect effects of CYTOR lncRNA regulate HIV gene expression.
    PLoS Pathog. 2024;20:e1012172.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

31. KIZITO F, Nguyen K, Mbonye U, Shukla M, et al
    Structural rearrangements in the nucleus localize latent HIV proviruses to a perinucleolar compartment supportive of reactivation.
    Proc Natl Acad Sci U S A. 2024;121:e2202003121.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.